Since 2001, when the first draft of the Human Genome Project was announced, hope surged for genomic medicine to be a panacea for many health conditions from diagnosis to treatment. Soon after the project was complete in 2003, the early tangible examples of success did not match the high expectations of that time. But today, there is renewed confidence in the healthcare and life sciences industries that the hype could indeed match the hope. Consider what is different now:
A new genomic health record will become a reality as genomic information gets combined with relevant data extracted from the traditional EMR. Rapid, precision oncology decision support is expected to expand on a larger scale by performing sophisticated genome/proteome/RNA analysis coupled with cognitive computing. The capabilities and technologies associated with cognitive computing are critical to the ongoing genomic medicine evolution by enabling much more sophisticated decision support, innovative clinical trials, new targeted therapies, and a focus on health outcomes to prevent and alleviate disease symptoms.
To benefit from the far-reaching industry transformation that has begun, forward-thinking executives can: verify that genomic medicine is part of their enterprise vision and strategy; assess and plan to fill existing and future skill gaps; and look closely at how and when partnering will help their organizations succeed in meeting stakeholder needs.
Register to download the IBM Institute for Business Value Executive Report
About the authors
IBM Watson Group, Healthcare and Life Sciences expert
Connect with Aditya Pai
Takahiko Koyama, PhD
IBM Research, Lead scientist in genomic medicine
IBM Software Group, Industry portfolio manager, public sector solutions
IBM Institute for Business Value, Global Life Sciences and Healthcare Lead
What is Watson?
Learn how cognitive computing systems help human experts make better decisions by penetrating the complexity of Big Data.
Download the IBV App
Access our latest thought leadership, including C-suite studies and industry insights. Maintain a library, receive regular updates. Explore enhanced content.
Sign up to receive monthly e-mail updates on recent papers from the IBM Institute for Business Value.
Healthcare & Life Sciences consulting
Research, analysis and solutions to address critical business issues in the life sciences industry.